Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.3K Hold
150
– – 0.02% 154
2026
Q1
$52.8K Hold
150
– – 0.03% 139
2025
Q4
$49.1K Hold
150
– – 0.03% 140
2025
Q3
$42.3K Hold
150
– – 0.03% 145
2025
Q2
$41.9K Hold
150
– – 0.03% 141
2025
Q1
$46.7K Hold
150
– – 0.03% 126
2024
Q4
$39.1K Buy
+150
New +$44.5K 0.03% 138

Other funds holding AMGN

Graney & King's AMGN Position: Q2 2026 in Review

Graney & King held its Amgen (AMGN) position steady in Q2 2026 at 150 shares worth $54.3K. The position accounts for 0.02% of the portfolio, ranked #154.

Graney & King first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Graney & King held 150 shares of Amgen worth $54.3K as of Q2 2026.
  • Graney & King left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.02% of Graney & King's portfolio in Q2 2026, its #154 holding.
  • Graney & King first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.